2019 Bioburden Testing Industry Mergers and Acquisitions Report: Supplier Performance Benchmarking, Latest Market Trends, Competitive Intelligence And Regional Overview By 2026 | Charles River (U.S.), Merck KGaA (Germany), SGS SA (Switzerland)

Bioburden Testing Market Snapshot:

The Bioburden testing market was valued at USD 652 million in 2017 and is expected to grow at a CAGR of 15.4% during the forecast period 2019-2026.

Bioburden testing is a modern day application used to measure the total number of viable micro-organisms on medical devices, raw material, and packaging food as the presence of these organisms can cause severe health issues. The prevalence of food poisoning is increasing at an alarming rate. To address to the situation, governments around the world are making it mandatory for the hospitals, dairy farms, and food industry among others to run their instruments through bio-burden testing before using them. Moreover, increasing application of bioburden testing in the pharmaceutical and biotechnology, medical device, food & beverage and agricultural products manufacturing industry is driving the market growth. Globally, the pharmaceuticals market is expected to grow from USD 1 trillion in 2015 to USD 1.3 trillion by 2020 at an annual growth rate of 4.9%.

The consumables segment is leading the bioburden testing market on account of significantly growing demand from the pharmaceutical and food industry. In addition, for bioburden testing, the consumables reagents and kits are available in ready to use culture media. For instance, Merck KGaA, offers Milliflex Quantum bioburden testing reagent kit for easy-to-use system and rapid detection of organisms. Bioburden testing is a non-destructive technology that can easily recover and collect any microorganisms using existing ID technology. In addition, it is an easy to use, flexible technology it can aslo provide consistent results across all applications.

Aerobic count testing segment holds the largest market share. In the environment, there are millions of pathogenic micro-organisms that has the potential to create severe complications, here’s where aerobic count testing steps in. Moreover, it is mandatory for the manufacturers to calculate the total aerobic microbial count in the pharmaceutical, food, and cosmetics industries.

North America accounted for largest share of bioburden testing market. Increasing prevalence of food borne illness in U.S. due to increasing contamination in Food and beverages is influencing demand for bioburden testing.  For instance, Centres for Diseases Control and Prevention, in 2018, around 48 million people affected due to food borne illness in U.S. Moreover, Government regulation and general guidelines for pharmaceutical industries for bioburden testing is major factor for the growth of market. For instance, Federal Regulations such as (CFR) 21 CFR 211.113 and recommended USP microbiological examination of pharmaceutical nonsterile products. Adoption of new technologies has led to harmonization of quality and standards in the healthcare industry.  Furthermore, around 2.7% of GDP of U.S. spend on research & development is major opportunity for market growth. Moreover, increasing incidence of food recall adulterated due to possible product contamination due to microorganisms is also influencing demand for bioburden testing market. For instance, In July 2019, The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced recalled around 712 lbs. of raw beef and pork products due to contamination.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/bioburden-testing-market/request-sample

The Major Prominent Players Covered in this Report:
Charles River (U.S.), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), BD Company (U.S.), North Americanscience Associates Inc. (U.S.), Nelson Laboratories, LLC (U.S.), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (U.S.)

By Product: Aerobic Count Testing, Anaerobic Count Testing, Fungi/Mold Count Testing, Spores Count Testing
By Application: Raw Material Testing, Medical Device Testing, In-process Testing, Sterilization Validation Testing, Equipment Cleaning Validation
By End User: Pharmaceutical and Biotechnology Companies, Medical Device Manufacturers, Contract Manufacturing Organizations (CMOs), Manufacturers of Food & Beverage and Agricultural Products, Microbial Testing Laboratories

Key Finding:
Rising safety concerns related to food and beverage products
Expanding medical devices, pharmaceutical, and biotechnology industries
Growing number of product recalls as a result of microbial contamination
Increasing use of biotechnology in the food and agriculture industries

Future Developments:
Fast & easy systems to be employed to detect microbial contamination
Emerging economies to focus on innovations of bioburden technology

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Bioburden Testing in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Bioburden Testing market during the forecast period 2019-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Bioburden Testing and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Bioburden Testing. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ https://straitsresearch.com/report/bioburden-testing-market/toc

Key Questions Answered in The Report:
What will the Bioburden Testing market growth rate?
What are the key factors driving the global Bioburden Testing market?
Who are the key manufacturers in the Bioburden Testing market space?
What are the market opportunities, market risk, and market overview of the Bioburden Testing market?
What are sales, revenue, and price analysis of top manufacturers of the Bioburden Testing market?
Who are the distributors, traders, and dealers of the Bioburden Testing market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Bioburden Testing Industry?
What are sales, revenue, and price analysis by regions of Bioburden Testing industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Bioburden Testing Market Trends:
- The report identifies, determines, and forecasts the Global Bioburden Testing Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Bioburden Testing Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Bioburden Testing Market.

Browse Full Report @ 
https://straitsresearch.com/report/bioburden-testing-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/bioburden-testing-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enable us to determine greater insights by eliminating the research costs.

This release was published on openPR.